Endoscopic delivery of medical devices

(19)

(11)

EP 2 559 388 B8

(12)	CORRECTED EUROPEAN PATENT SPECIFICATION
	Note: Bibliography reflects the latest situation

(15)	Correction information:
	Corrected version no 1 (W1 B1)

(48)	Corrigendum issued on:
	12.03.2014 Bulletin 2014/11

(45)	Mention of the grant of the patent:
	29.01.2014 Bulletin 2014/05

(21)	Application number: 12187668.4

(22)	Date of filing: 27.04.2005

(51)

International Patent Classification (IPC):

A61B 1/00^(2006.01)
A61B 1/303^(2006.01)
A61B 5/00^(2006.01)
A61B 17/42^(2006.01)

A61B 1/018^(2006.01)
A61B 1/04^(2006.01)
A61B 17/12^(2006.01)
A61F 6/22^(2006.01)

(54)	Endoscopic delivery of medical devices Endoskopische Verabreichung von medizinischen Vorrichtungen Administration endoscopique de dispositifs médicaux

(84)	Designated Contracting States:
	DE ES FR GB IT

(30)

Priority:

28.04.2004 US 566190 P

(43)	Date of publication of application:
	20.02.2013 Bulletin 2013/08

(62)	Application number of the earlier application in accordance with Art. 76 EPC:
	05741823.8 / 1740133

(73)	Proprietor: Bayer Essure Inc.
	Milpitas, CA 95035 (US)

(72)	Inventors:
	Callister, Jeffery, P. Deephaven, MN 55391 (US) Tremulis, William, S. Redwood City, CA 94065 (US) Kemp, Laura Los Gatos, CA 95032 (US) Stull Paul, M. Bodega Bay, CA 94923 (US)

(74)	Representative: Lloyd, Robin et al
	Kilburn & Strode LLP 20 Red Lion Street London WC1R 4PJ London WC1R 4PJ (GB)

(56)

References cited: :

WO-A-01/13833
US-A- 5 919 202

WO-A-94/26175
US-A- 6 090 063

Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).